A clinical trial on the effect of lactulose on defaecation frequency.

Not Applicable

• Conditions: ot applicable

• Registration Number: JPRN-UMIN000050599
• Lead Sponsor: Matsumoto Health Lab

Brief Summary

Not available

Detailed Description

Not available

Study Timeline

• Results First Posted: 1900-01-01
• Study Start: 2023-03-15
• Study Completion: 2023-08-31
• Last Update Posted: 17 October 2023

Recruitment & Eligibility

• Status: Pending
• Sex: All
• Target Recruitment: 70

Inclusion Criteria

Not provided

Exclusion Criteria

1) Subjects with severe hepatic, renal, heart, gastrointestinal, cerebrovascular, endocrine, metabolic or infection diseases. 2) Subjects with the history of gastrointestinal resection. 3) Subjects with gastrointestinal dysfunction such as irritable bowel syndrome or inflammatory bowel disease. 4) Subjects who regularly use medicine that affect the gut microbiota (e.g, antibiotics, active bacterial preparations, laxatives, antidiarrheals), supplements (including lactic acid bacteria, bifidobacteria, oligosaccharides, dietary fiber, etc.), or foods with functional claims that claim to improve the gut microbiota. 5) Subjects with milk allergy or lactose intolerance. 6) Subjects who participate another study. 7) Subjects who are judged inappropriate for the study by the investigator or the physician.

Study & Design

• Study Type: Interventional
• Study Design: Not specified

Primary Outcome Measures

Name	Time	Method
defaecation frequency

Secondary Outcome Measures

Name	Time	Method
faecal microbiota